ADUS
Addus HomeCare Corporation
NASDAQ: ADUS · HEALTHCARE · MEDICAL CARE FACILITIES
$97.79
+2.68% today
Updated 2026-06-05
Market cap
$1.83B
P/E ratio
18.04
P/S ratio
1.26x
EPS (TTM)
$5.42
Dividend yield
—
52W range
$91 – $124
Volume
0.3M
WallStSmart proprietary scores
60
out of 100
Grade: C+
Hold
Investment rating
7.3
Growth
B+8.0
Quality
A5.5
Profitability
C+6.0
Valuation
B5/9
Piotroski F-Score
Moderate
3.7
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$133.46
+36.48%
12-Month target
$124.17
+26.98%
Intrinsic (DCF)
$104.58
Margin of safety
-7.73%
3 Strong Buy9 Buy1 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 3.71 — safe zone
+ Free cash flow $50.65M — positive
+ Debt/equity 0.12x — low leverage
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $951.12M | $1.06B | $1.15B | $1.42B | $1.45B |
| Net income | $46.02M | $62.52M | $73.60M | $95.91M | $25.07M |
| EPS | — | — | — | — | $5.42 |
| Free cash flow | $96.81M | $102.79M | $110.38M | $103.79M | $50.65M |
| Profit margin | 4.84% | 5.91% | 6.37% | 6.74% | 6.89% |
Peer comparison
Smart narrative
Addus HomeCare Corporation trades at $97.79. representing a P/E of 18.04x trailing earnings. Our Smart Value Score of 60/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 3.71, it sits in the safe zone. TTM revenue stands at $1.45B. with profit margins at 6.89%. Our DCF model estimates intrinsic value at $104.58.
Frequently asked questions
What is Addus HomeCare Corporation's stock price?
Addus HomeCare Corporation (ADUS) trades at $97.79, on a P/E of 18.0x and a P/S of 1.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Addus HomeCare Corporation overvalued?
Addus HomeCare Corporation carries a Smart Value Score of 60/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $104.58 against the $97.79 price, so on cash flow terms the market is paying a premium for Addus HomeCare Corporation's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Addus HomeCare Corporation (ADUS)?
The 12-month analyst consensus target is $133.46, about 36.5% above the current $97.79. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Addus HomeCare Corporation (ADUS)?
Our DCF model estimates intrinsic value at $104.58, a -7.7% margin of safety versus today's $97.79. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Addus HomeCare Corporation's revenue?
Addus HomeCare Corporation's trailing twelve-month revenue is $1.45B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Addus HomeCare Corporation's Altman Z-Score is 3.71, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.26x
ROE8.94%
Beta0.92
50D MA$97.77
200D MA$108.99
Shares out0.02B
Float0.02B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—